Sana Biotechnology

Company snapshot

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients wit

• 1 approved product(s) across US/EU regulatory metadata.
• 19 active pipeline program(s) linked via ClinicalTrials.gov.
• 136 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Sana Biotechnology. Not investment advice.

• Peer + 0 momentum

  Novartis India

  TA overlap score 40

• Peer + 0 momentum

  Eli Lilly and

  TA overlap score 32.4

Recent activity

Latest pipeline, patent, and corporate events for Sana Biotechnology.

1. Jun 14, 2026 Clinical update

   TREAT LMNA — Phase 2

2. Jun 8, 2026 Clinical update

   TARGET2020 — Approved

3. Jun 8, 2026 Clinical update

   GN-002 — Phase 2

4. Jun 8, 2026 Clinical update

   Sodio ioduro (I131) Curium Netherlands 37-740... — Phase 3

5. Jun 8, 2026 Clinical update

   PITAC_ MaPEPi — Phase 2

View all clinical trial activity →

• What is Sana Biotechnology?

  Sana Biotechnology is a biotech organization headquartered in Seattle, USA. It trades on NYSE under ticker SANA. Primary therapeutic focus areas include Breast Cancer, Pleural carcinosis, Parkinson’s Disease, Graves' disease and Graves' orbitophaty, haematologic condition who nee

• Is Sana Biotechnology publicly traded?

  Yes. Sana Biotechnology is listed with ticker SANA on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Sana Biotechnology develop or market?

  We link 22 drug profile(s) where Sana Biotechnology is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/sana-biotechnology#company-drugs.

• What are the latest developments for Sana Biotechnology?

  In the last 12 months our linked public records show 19 trial program update(s) and 2 US patent grant(s) tied to this profile.

• What therapeutic areas does Sana Biotechnology focus on?

  Sana Biotechnology focuses on Breast Cancer, Pleural carcinosis, Parkinson’s Disease based on our analysis of their pipeline programs and drug development activities.